These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19181521)

  • 1. Design, synthesis, and biological evaluation of 1,5-benzothiazepine-4-one derivatives targeting factor VIIa/tissue factor.
    Ayral E; Gloanec P; Bergé G; de Nanteuil G; Mennecier P; Rupin A; Verbeuren TJ; Fulcrand P; Martinez J; Hernandez JF
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1386-91. PubMed ID: 19181521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of pyrazinones containing novel P1 needles as inhibitors of TF/VIIa.
    Trujillo JI; Huang HC; Neumann WL; Mahoney MW; Long S; Huang W; Garland DJ; Kusturin C; Abbas Z; South MS; Reitz DB
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4568-74. PubMed ID: 17566736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition.
    Klingler O; Matter H; Schudok M; Donghi M; Czech J; Lorenz M; Nestler HP; Szillat H; Schreuder H
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3715-20. PubMed ID: 15203149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.
    Zbinden KG; Obst-Sander U; Hilpert K; Kühne H; Banner DW; Böhm HJ; Stahl M; Ackermann J; Alig L; Weber L; Wessel HP; Riederer MA; Tschopp TB; Lavé T
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5344-52. PubMed ID: 16213138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors.
    Groebke Zbinden K; Banner DW; Ackermann J; D'Arcy A; Kirchhofer D; Ji YH; Tschopp TB; Wallbaum S; Weber L
    Bioorg Med Chem Lett; 2005 Feb; 15(3):817-22. PubMed ID: 15664864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Factor VIIa/tissue factor.
    Shirk RA; Vlasuk GP
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a novel series of 1,5-benzothiazepine derivatives as potential antimicrobial agents.
    Wang L; Zhang P; Zhang X; Zhang Y; Li Y; Wang Y
    Eur J Med Chem; 2009 Jul; 44(7):2815-21. PubMed ID: 19144450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel heterocyclic factor VIIa inhibitors.
    Rai R; Kolesnikov A; Sprengeler PA; Torkelson S; Ton T; Katz BA; Yu C; Hendrix J; Shrader WD; Stephens R; Cabuslay R; Sanford E; Young WB
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2270-3. PubMed ID: 16460932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.
    Kohrt JT; Filipski KJ; Cody WL; Cai C; Dudley DA; Van Huis CA; Willardsen JA; Narasimhan LS; Zhang E; Rapundalo ST; Saiya-Cork K; Leadley RJ; Edmunds JJ
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1060-4. PubMed ID: 16289811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors.
    Parlow JJ; Kurumbail RG; Stegeman RA; Stevens AM; Stallings WC; South MS
    J Med Chem; 2003 Oct; 46(22):4696-701. PubMed ID: 14561089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of some new substituted benzothiazepine and benzoxazepine derivatives as anticonvulsant agents.
    Garg N; Chandra T; Archana ; Jain AB; Kumar A
    Eur J Med Chem; 2010 Apr; 45(4):1529-35. PubMed ID: 20163892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands.
    Miura M; Seki N; Koike T; Ishihara T; Niimi T; Hirayama F; Shigenaga T; Sakai-Moritani Y; Tagawa A; Kawasaki T; Sakamoto S; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2007 Jan; 15(1):160-73. PubMed ID: 17064913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-assisted solution-phase library synthesis and crystal structure of alpha-ketothiazoles as tissue factor VIIa inhibitors.
    Parlow JJ; Dice TA; Lachance RM; Girard TJ; Stevens AM; Stegeman RA; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4043-9. PubMed ID: 12954057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity.
    Groebke Zbinden K; Banner DW; Hilpert K; Himber J; Lavé T; Riederer MA; Stahl M; Tschopp TB; Obst-Sander U
    Bioorg Med Chem; 2006 Aug; 14(15):5357-69. PubMed ID: 16621574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors.
    Buckman BO; Chou YL; McCarrick M; Liang A; Lentz D; Mohan R; Morrissey MM; Shaw KJ; Trinh L; Light DR
    Bioorg Med Chem Lett; 2005 May; 15(9):2249-52. PubMed ID: 15837303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quest for Factor VIIa exosite inhibitors.
    Amour A; Hutchinson J; Ruiz Avendaño AM; Ratcliffe S; Alvarez E; Martin J; Toomey JR; Senger S; Wolfendale M; Mooney C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):555-8. PubMed ID: 17511650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective TF/FVIIa inhibitors containing a neutral P1 ligand.
    Miura M; Seki N; Koike T; Ishihara T; Niimi T; Hirayama F; Shigenaga T; Sakai-Moritani Y; Kawasaki T; Sakamoto S; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2006 Dec; 14(23):7688-705. PubMed ID: 16942884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of the tissue factor/factor VIIa-induced coagulation: synthesis and in vitro evaluation of novel 2-aryl substituted pyrid.
    Jakobsen P; Horneman AM; Persson E
    Bioorg Med Chem; 2000 Dec; 8(12):2803-12. PubMed ID: 11131171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
    Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.